Skip to main content
Advertisement
Advertisement

BIVI

BIVI logo

BioVie, Inc. Common Stock

1.61
USD
Sponsored
-0.02
-1.23%
Sep 24, 15:45 UTC -4
Closed
exchange

Pre-Market

1.72

+0.11
+6.83%

BIVI Earnings Reports

Positive Surprise Ratio

BIVI beat 8 of 13 last estimates.

62%

Next Report

Date of Next Report
Nov 09, 2026
Estimate for Q1 27 (Revenue/ EPS)
--
/
--
Implied change from Q4 26 (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--

BioVie, Inc. Common Stock earnings per share and revenue

On Aug 13, 2026, BIVI reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.53 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -10.26% price change (close before vs. close after earnings).
Looking ahead to Q1 27, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q4 2026, BioVie, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved down -10.26%, changed from $1.56 before the earnings release to $1.40 the day after.
The next earning report is scheduled for Nov 09, 2026.
Based on -- analysts, BioVie, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q1 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement